Private Advisor Group LLC Reduces Stock Holdings in The Clorox Company (NYSE:CLX)
Private Advisor Group LLC Reduces Stock Holdings in The Clorox Company (NYSE:CLX)
Private Advisor Group LLC decreased its stake in The Clorox Company (NYSE:CLX – Get Rating) by 3.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 31,236 shares of the company's stock after selling 1,235 shares during the quarter. Private Advisor Group LLC's holdings in Clorox were worth $1,452,614,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Federated Hermes Inc. lifted its stake in shares of Clorox by 86.2% during the 2nd quarter. Federated Hermes Inc. now owns 1,945,898 shares of the company's stock worth $274,332,000 after acquiring an additional 901,040 shares during the last quarter. State Street Corp lifted its stake in shares of Clorox by 9.6% during the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company's stock worth $1,255,721,000 after acquiring an additional 778,269 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Clorox by 5.6% during the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock worth $1,407,673,000 after acquiring an additional 580,982 shares during the last quarter. Two Sigma Investments LP raised its position in Clorox by 4,186.6% during the 3rd quarter. Two Sigma Investments LP now owns 303,622 shares of the company's stock valued at $38,982,000 after purchasing an additional 296,539 shares in the last quarter. Finally, Invesco Ltd. raised its position in Clorox by 38.2% during the 1st quarter. Invesco Ltd. now owns 1,051,679 shares of the company's stock valued at $146,216,000 after purchasing an additional 290,833 shares in the last quarter. Hedge funds and other institutional investors own 79.12% of the company's stock.
Get Clorox alerts:Clorox Stock Up 1.9 %
Shares of CLX stock opened at $157.50 on Monday. The Clorox Company has a 1-year low of $120.50 and a 1-year high of $160.59. The stock's fifty day moving average price is $150.56 and its 200 day moving average price is $144.95. The company has a debt-to-equity ratio of 5.04, a current ratio of 0.86 and a quick ratio of 0.47. The company has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a price-to-earnings-growth ratio of 3.12 and a beta of 0.29.
Clorox (NYSE:CLX – Get Rating) last announced its earnings results on Thursday, February 2nd. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.32. Clorox had a return on equity of 89.97% and a net margin of 6.16%. The firm had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.66 billion. During the same period in the previous year, the business earned $0.66 EPS. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 4.23 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be paid a dividend of $1.18 per share. The ex-dividend date of this dividend is Tuesday, April 25th. This represents a $4.72 annualized dividend and a yield of 3.00%. Clorox's dividend payout ratio (DPR) is 134.86%.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research report on Friday, January 13th. Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $152.00 to $147.00 in a research report on Monday, March 20th. StockNews.com initiated coverage on Clorox in a research report on Thursday, March 16th. They set a "hold" rating for the company. UBS Group boosted their price target on Clorox from $129.00 to $140.00 in a research report on Friday, February 3rd. Finally, Raymond James boosted their price target on Clorox from $160.00 to $165.00 and gave the stock an "outperform" rating in a research report on Friday, February 3rd. Seven analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $141.00.
Clorox Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Recommended Stories
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/20 – 3/24
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
根据Private Advisor Group LLC在最近提交给美国证券交易委员会的13F文件中称,第四季度该公司在The Clorox Company (NYSE:CLX - Get Rating)的股份减少了3.8%。该公司在本季度卖出1,235股后,拥有31,236股该公司的股票。在最近的报告期结束时,Private Advisor Group LLC在Clorox的持股价值为1,452,614,000美元。
其他一些机构投资者和对冲基金最近也修改了该股的持有量。联邦爱马仕公司在第二季度将其在高乐氏的股份提高了86.2%。联邦爱马仕公司在上个季度又收购了901,040股股票后,现在拥有该公司1,945,898股股票,价值274,332,000美元。State Street Corp在第二季度将其在Clorox的股份上调了9.6%。State Street Corp在上个季度又收购了778,269股股票后,现在拥有该公司8,907,083股股票,价值1,255,721,000美元。贝莱德公司在第三季度将其在Clorox的股份上调了5.6%。贝莱德公司在上个季度又收购了580,982股股票后,现在拥有该公司10,964,049股股票,价值1407,673,000美元。Two Sigma Investments LP在第三季度将其在高乐氏的头寸提高了4,186.6%。Two Sigma Investments LP在上个季度又购买了296,539股股票后,现在拥有该公司303,622股股票,价值38,982,000美元。最后,景顺有限公司在第一季度将其在高乐氏的头寸提高了38.2%。景顺有限公司在上个季度又购买了290,833股股票后,现在拥有该公司1,051,679股股票,价值146,216,000美元。对冲基金和其他机构投资者拥有该公司79.12%的股票。
获取 Clorox 警报:
高乐氏股票上涨1.9%
周一,CLX股票开盘价为157.50美元。高乐氏公司创下1年低点120.50美元,1年高点160.59美元。该股的五十天移动平均价格为150.56美元,其200天移动平均线价格为144.95美元。该公司的债务与权益比率为5.04,流动比率为0.86,速动比率为0.47。该公司的市值为194.6亿美元,市盈率为45.00,市盈增长率为3.12,beta值为0.29。
Clorox(纽约证券交易所代码:CLX — Get Rating)上次公布财报是在2月2日星期四。该公司报告本季度每股收益0.98美元,比市场普遍预期的0.66美元高出0.32美元。高乐氏的股本回报率为89.97%,净利润率为6.16%。该公司本季度的收入为17.2亿美元,而市场普遍预期为16.6亿美元。去年同期,该业务的每股收益为0.66美元。该公司本季度的收入同比增长1.4%。研究分析师平均预计,Clorox公司将在本财年公布每股收益4.23美元。
高乐氏宣布分红
该公司最近还宣布了季度股息,该股息将于5月12日星期五支付。4月26日星期三登记在册的投资者将获得每股1.18美元的股息。本次股息的除息日为4月25日星期二。这意味着年化股息为4.72美元,收益率为3.00%。高乐氏的股息支付率(DPR)为134.86%。
华尔街分析师权衡一下
许多股票研究分析师都对该公司进行了权衡。摩根大通在1月13日星期五的一份研究报告中将高乐氏的目标价格从126.00美元上调至135.00美元,并给该公司 “减持” 评级。德意志银行Aktiengesellschaft在3月20日星期一的一份研究报告中将高乐氏的目标价格从152.00美元下调至147.00美元。StockNews.com在3月16日星期四的一份研究报告中开始报道高乐氏。他们为公司设定了 “持有” 评级。瑞银集团在2月3日星期五的一份研究报告中将高乐氏的目标股价从129.00美元上调至140.00美元。最后,雷蒙德·詹姆斯在2月3日星期五的一份研究报告中将高乐氏的目标股价从160.00美元上调至165.00美元,并将该股评为 “跑赢大盘”。七位分析师对该股进行了卖出评级,六位分析师给出了持有评级,一位给出了该公司的股票买入评级。根据MarketBeat的数据,高乐氏目前的共识评级为 “持有”,共识目标价为141.00美元。
高乐氏简介
(获取评级)
Clorox Co从事消费品和专业产品的制造和销售。它通过以下业务领域运营:健康与保健、家居、生活方式和国际业务。健康与保健部门包括清洁产品、专业产品和维生素、矿物质和补品,主要在美国销售和销售。
推荐故事
免费获取 StockNews.com 关于高乐氏 (CLX) 的研究报告的副本
MarketBeat Week 回顾 — 3 月 20 日 — 3 月 24 日
Diversion King 原装零件公司在利润指导上
埃森哲已经触底了
2023 年 11 只最佳非必需消费品股
5 只最佳股息捕获股票
接收 Clorox Daily 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Clorox及相关公司的最新新闻和分析师评级的简要每日摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧